Antibody-dependent enhancement
Antibody-Dependent Enhancement (ADE) is a phenomenon in which the presence of specific antibodies increases the entry of a virus into cells and, consequently, enhances the viral infectivity. ADE is observed in various viral infections, including Dengue, HIV, and SARS-CoV-2, among others. This mechanism can lead to both increased severity of infection and altered immune responses.
Mechanism[edit | edit source]
ADE occurs through two primary mechanisms: Fc receptor-mediated and complement receptor-mediated enhancement. In Fc receptor-mediated ADE, virus-antibody complexes bind to Fcγ receptors on the surface of certain immune cells, facilitating viral entry. In complement receptor-mediated ADE, the virus-antibody complexes activate the complement system, leading to the deposition of complement proteins that enhance viral entry through complement receptors.
Clinical Implications[edit | edit source]
The clinical implications of ADE are significant, particularly in the context of viral infections and vaccine development. For diseases like Dengue, secondary infections with a different serotype of the virus can lead to severe dengue hemorrhagic fever or dengue shock syndrome, conditions thought to be exacerbated by ADE. In the context of vaccine development, there is a concern that vaccines could induce antibodies that do not neutralize the virus effectively, leading to ADE and, consequently, more severe disease upon infection.
Research and Vaccine Development[edit | edit source]
Research into ADE is critical for the development of safe and effective vaccines, especially for viruses with a high risk of ADE. Vaccine developers aim to design vaccines that elicit a strong neutralizing antibody response without increasing the risk of ADE. This involves careful selection of vaccine antigens and adjuvants, as well as thorough evaluation of vaccine-induced immune responses in preclinical and clinical studies.
Conclusion[edit | edit source]
ADE is a complex phenomenon that poses challenges to the understanding of viral pathogenesis and vaccine development. Ongoing research is essential to unravel the mechanisms underlying ADE and to develop strategies to mitigate its effects in viral infections and vaccine-induced responses.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD